Publication: Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
Issued Date
2018-07-02
Resource Type
ISSN
16112156
Other identifier(s)
2-s2.0-85051517659
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
EXCLI Journal. Vol.17, (2018), 634-646
Suggested Citation
Kannika Permpoonputtana, Patlada Tangweerasing, Sujira Mukda, Parichart Boontem, Chutikorn Nopparat, Piyarat Govitrapong Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain. EXCLI Journal. Vol.17, (2018), 634-646. doi:10.17179/excli2017-654 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/44717
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
Other Contributor(s)
Abstract
© 2018, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved. Aging is often accompanied by a decline in cognitive function in conjunction with a variety of neurobiological changes, including neuroinflammation. Melatonin is a key endogenous indoleamine secreted by the pineal gland that plays a crucial role in the regulation of circadian rhythms, is a potent free radical scavenger, has anti-inflammatory activity and serves numerous other functions. However, the role of melatonin in sterile inflammation in the brain has not been fully investigated. In the present study, we investigated the neuroinflammation status in aged mouse brains. The results showed that the protein levels of integrin αM (CD11b), glial fibrillary acidic protein (GFAP), the major pro-inflammatory cytokines (interleukin-1 beta [IL-1β], interleukin-6 [IL-6], and tumor necrosis factor alpha [TNF-α]) and phosphor-nuclear factor kappa B (pNFκB) were significantly increased, while Nmethyl- D-aspartate (NMDA) receptor subunits NR2A and NR2B, Ca2+/calmodulin-dependent protein kinase II (CaMKII), and brain-derived neurotrophic factor (BDNF) were down-regulated in the hippocampus and prefrontal cortex (PFC) of 22-months-old (aged) mice compared with 2-months-old (young adult) mice. Melatonin was administered in the drinking water to a cohort of the aged mice at a dose of 10 mg/kg/day, beginning at an age of 16 months for 6 months. Our results revealed that melatonin significantly attenuated the alterations in these protein levels. The present study suggests an advantageous role for melatonin in anti-inflammation, and this may lead to the prevention of memory impairment in aging.